NDC 71336-1000

Onpattro

Patisiran

Onpattro is a Intravenous Injection, Lipid Complex in the Human Prescription Drug category. It is labeled and distributed by Alnylam Pharmaceuticals, Inc.. The primary component is Patisiran Sodium.

Product ID71336-1000_2d0db5c1-a61b-4e1a-bf87-534af4150b34
NDC71336-1000
Product TypeHuman Prescription Drug
Proprietary NameOnpattro
Generic NamePatisiran
Dosage FormInjection, Lipid Complex
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-08-13
Marketing CategoryNDA / NDA
Application NumberNDA210922
Labeler NameAlnylam Pharmaceuticals, Inc.
Substance NamePATISIRAN SODIUM
Active Ingredient Strength2 mg/mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71336-1000-1

1 VIAL, SINGLE-DOSE in 1 CARTON (71336-1000-1) > 5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2018-08-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71336-1000-1 [71336100001]

Onpattro INJECTION, LIPID COMPLEX
Marketing CategoryNDA
Application NumberNDA210922
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-08-13

Drug Details

Active Ingredients

IngredientStrength
PATISIRAN SODIUM2 mg/mL

OpenFDA Data

SPL SET ID:e87ec36f-b4b4-49d4-aea4-d4ffb09b0970
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2053529
  • 2053524

  • Trademark Results [Onpattro]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ONPATTRO
    ONPATTRO
    88637585 not registered Live/Pending
    Alnylam Pharmaceuticals, Inc.
    2019-10-01
    ONPATTRO
    ONPATTRO
    87569917 5591475 Live/Registered
    Alnylam Pharmaceuticals, Inc.
    2017-08-15
    ONPATTRO
    ONPATTRO
    86944919 5596122 Live/Registered
    Alnylam Pharmaceuticals, Inc.
    2016-03-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.